Thesis Based on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)’s imminent catalysts (Reproxalap), considering the company holds $133 million in cash, cash equivalents and marketable securities, as
Marvell Technology (NASDAQ:MRVL) is a key supplier of data center infrastructure semiconductor solutions for data center core and network edge. Marvell’s data center business
An alternative trading platform CEO wants to revolutionize private equity investing to help mitigate a stalling initial public offering market. So, Forge Global’s Kelly